Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Induction of IFNα or IL-12 depends on differentiation of THP-1 cells in dengue infections without and with antibody enhancement

  • Rong-Fu Chen1,
  • Lin Wang2,
  • Jiin-Tsuey Cheng3 and
  • Kuender D Yang1Email author
BMC Infectious Diseases201212:340

DOI: 10.1186/1471-2334-12-340

Received: 15 May 2012

Accepted: 4 December 2012

Published: 8 December 2012

Abstract

Background

Appropriate induction of the early Th1 cytokine IL-12 is a critical defense directed against viral infection. We have previously shown that different viruses elicited either IL-12 or IFNα dependent Th1 reactions. Using dengue-2 virus, we sought to explore how dengue-2 induced IL-12 or IFNα expression by monocytic and its derived dendritic cells.

Methods

We employed human monocytic cell line, THP-1, to investigate whether differentiation of monocytic cells is involved in the switch between IFNα and IL-12 induction. Flow cytometry, RT-PCR and ELISA were respectively used to determine cell differentiation, IL-12 and IFNα mRNA expression and protein production.

Results

THP-1, expressing CD123, which is a plasmacytoid dendritic cell marker, but not CD14, CD11b or CD11c revealed IFNα mRNA expression while stimulated by dengue-2. In contrast, PMA-induced THP-1 differentiation toward monocytic cells expressed CD11b+, and CD14+, but not CD123, and revealed exclusively IL-12 expression while stimulated by dengue-2. Further studies showed that CD123+ expressing THP-1 cells elicited higher IFNα expression in dose and time dependent induction after infection, and PMA-induced monocytic differentiation of THP-1 cells revealed IL-12 expression. Antibody-dependent enhancement of DEN-2 infection significantly suppressed the DEN-2 induced IL-12 p40 expression in monocytic differentiated THP-1 cells.

Conclusions

Clarification and modulation of the early Th1 reaction in different monocytic cells may change or prevent complication from dengue infection.

Keywords

Monocyte Deneritic cells Differentiation CD123 IFNα IL-12

Background

Dengue fever (DF) is transmitted by mosquitoe bite which introduces dengue viruses (DEN) including 4 serotypes. DF is highly prevalent in tropical and subtropical areas, with at least 50 million new cases each year [1, 2]. Occasional, DF progresses to dengue hemorrhagic fever (DHF), a potentially life threatening complication associated with vascular leakage, hemorrhage, thrombocytopenia and shock [35]. More than 1 billion people are at risk of dengue infection and there are approximately 100 million cases of DF and 500,000 cases of DHF every year [6]. DHF has been classified into four grades on the basis of clinical presentation. The mildest is grade I and the most severe is grade IV [7, 8]. The first indication of an immunological mechanism for DHF was the observation in a Bangkok outbreak of DHF in 1960s [9]. In that outbreak, over 85% of children with DHF had high DEN heterotypic cross-reactive antibody titers, suggesting an antibody-dependent enhancement (ADE) of DEN infection in the pathogenesis [10]. Monocytes, macrophages and dendritic cells (DCs) play a crucial role in immune responses against virus infection, in which IL-12 and IFN α/β are early mediators of Th1 cell immunity [1113]. It is well known that IL-12 derived from monocytes or dendritic cells can polarize Th1 reaction [1416]. Whether type I interferons are involved in IFNγ induction mediating Th1 reaction remains controversial [17, 18]. Recently, we have found that different microorganisms could induce IL-12 or IFNα to polarize Th1 reaction in a mutually exclusive fashion [16]. Different viruses induce IL-12 or IFNα mutually exclusive is usually mediated via ligation of different toll-like receptors (TLRs) [1921].

DCs play a central role in the initiation of T cell-mediated antiviral immune responses [22, 23]. Different DCs release different cytokines to polarize T helper (Th) cells. Plasmacytoid DCs release IFN α/β to polarize Th1 reaction [24], myeloid DCs release mainly IL-12 to enhance Th1 reaction [25], and regulatory DCs release IL-10 or TGFβ to polarize Treg [26]. Besides, DCs are very effective at taking up antigen, by pinocytosis of soluble compounds, macropinocytosis of high-molecular-weight antigens and phagocytosis of particles [27]. After encountering antigen, DCs migrate to the lymph nodes where DCs activate specific T cells [28]. The migration is dependent on the expression of chemokine receptors, which enable the cells to sense chemotactic gradients, and cell adhesion molecules for interaction with endothelial cells. Several of these molecules play important regulatory roles, such as ALCAM, which is expressed on activated T cells and on monocyte-derived DCs, and might play a role in DC migration [29].

We have previously shown that DHF, a potential fatal complication of DF, is associated with higher Th2 reaction [3032] and lower Th1 polarization [33]. Moreover, we have also demonstrated that varicella-zoster virus and Bacillus Calmette-Guerin (BCG) induce IFNα and IL-12 production, respectively [16]. This study was conducted to investigate whether differentiation of monocytic cells is involved in the switch between IFNα and IL-12 induction after dengue infection, and whether ADE of dengue infection could modulate the production of IFNα and IL-12 by different monocytic cells.

Monocytes and macrophages are recruited to sites of inflammation and play critical roles in innate host defense mechanisms. THP-1, human promonocytic leukemia cells, grow as nonadherent promonocytes, and differentiate to macrophage-like cells upon treatment with PMA [34, 35]. PMA, a potent activator of PKC, arrests THP-1 proliferation and induces the expression of several macrophage characteristics [3638]. It remains unclear whether THP-1 monocytic cells can express IFNα or IL-12, depending on differentiation; or THP-1 monocytic can develop into different DCs, responsible for exclusive IFNα or IL-12 expression. ADE of dengue has long been implicated in severe, usually secondary, DEN infections. Preexisting heterotypic antibodies of dengue might promote dengue infection via their Fc-gamma receptor (FcγR) [39], this may not only facilitate the virus’ entry, but also modifies innate and adaptive immune responses [40]. Employing DEN-2 virus, which is known to cause the most outbreaks of DHF, associated with altered Th1/Th2 reaction [4145], we attempted to explore DEN-2 virus induction of IFNα or IL-12 in a monocytic differentiation model.

Methods

Reagents and medium

Phorbol 12-myristate 13-acetate (PMA), and dimethyl sulfoxide (DMSO) were purchased from Sigma Chemical Co. (St. Louis, MO). RPMI 1640 culture medium was obtained from Gibco BRL (Grand Island, NY, USA). Fetal bovine serum (FBS), gentamicin, and L-glutamine were purchased from Gibco BRL, Inc. (Grand Island, N.Y., USA).

Cells culture

Monocytic THP-1 cells were grown in RPMI 1640, 10% FBS (endotoxin level <0.25 EU/mL; Gibco BRL, Grand Island, N.Y., USA), 2 mM L-glutamine (Gibco BRL, Grand Island, N.Y., USA) at 37°C, and 5% CO2 incubator. THP-1 cells (2×105 cells/ml) were subcultured every 3 days, and PMA (8 nM) was used to induce THP-1 cell differentiation. To study time dependent effect, cells (2×106 cells/ml) were used for studies with dengue-2 infection at multiplicity of infection (MOI) = 1.0 for 6 to 72 hours as indicated. For studying different infection dose, we used MOI from 0.1, 0.5, 1, 5 and 10 to study its dose-dependent effect.

Dengue-2 virus preparation

Dengue virus type 2 (DEN-2, New Guinea C strain, ATCC) was obtained from the Institute of Preventive Medicine, National Defense Medical Center, Taipei. Viruses were propagated in C6/36 mosquito cells in Eagle's minimal essential medium (MEM) (Gibco BRL, Grand Island, N.Y., USA) containing nonessential amino acids (Gibco BRL, Grand Island, N.Y., USA), 1% sodium pyruvate, 0.2% sodium bicarbonate and supplemented with 1% antibiotic (Gibco BRL, Grand Island, N.Y., USA) and 10% heat-inactivated FBS at 28°C for 5 days. Baby hamster kidney cells (BHK-21) were grown in MEM as described above. A large collection of virus culture was pooled and showed a titer of 1.0 × 107 PFU/ml determined by real-time quantitative RT-PCR as previously described [30]. All experiments about DEN infection were set at MOI = 1.

Flow cytometric analyses of cell surface markers

In order to characterize the change of cell differentiation markers on THP-1 cells, we measured pDC-specific and mDC-specific markers on THP-1 cells by flow cytometry. These cells (2 × 106 cells/ml) are treated with and without 8 nM PMA for 72 hours. Cell surface stainings were performed by direct immunofluorescent assay with fluorescence-conjugated mAbs (CD14-PE, CD11b-PE, CD11c-PE, and CD123-FITC) and corresponding isotype control antibodies for 30 minutes. After washing in PBS twice, cells were fixed in 2% paraformaldehyde for 20 min, washed, and resuspended at ~106 cells per milliliter before acquisition.

Real-time quantitative RT-PCR analysis of IL12B and IFNα mRNA expression

We subjected total RNA extracted from THP-1 cells with and without differentiation treatment to quantitative analysis of mRNA expression of IL12B and IFNα. In brief, the cell pellet was mixed with 0.5 ml of Tri-Zol solution (Invitrogen, California, USA). After thorough vortexing, samples were added 0.1 ml of chloroform (Scharlau, sa, Barcelona, European Union) for phase separation. After centrifugation, the upper aqueous phase was transferred to a fresh DEPC-treated eppendorf and the same volume of isopropanol (Merck KGaA, Darmstadt, Germany) was added for RNA precipitation at −20°C for 1 hour. The RNA was harvested by centrifugation at 12,000 × g for 10 minutes at 4°C, followed by 75% ethanol (Merck KGaA, Darmstadt, Germany) precipitation. Finally, the RNA was subjected to the real-time RT-PCR detection with SYBR Green PCR reagents (RealQ-PCR Master Mix Kit, Ampliqon) using the ABI PRISM 7500 instrument (Applied Biosystems, Foster City, CA) as previously described [46]. Primers for the quantitative detection of target mRNAs were designed by using Primer Express computer software (Applied Biosystem, Foster City, CA). For the IL12B gene, the primer sequences were 5’- acctccacctgccgagaat-3’ (forward) and 5’- acctccacctgccgagaat-3’ (reverse). For the IFNα. gene, the primer sequences were 5’-atttctgctctgacaacctc-3’ (forward) and 5’-tgacagagactcccctgatg-3’ (reverse) [47]. In order to evaluate PCR efficiency, a 3 replicates and 5-log dilution series were performed. A slope of −3.3 ±10% reflects an efficiency of 100% ±10%. Samples were analyzed in three independent duplicate experiments. The RT-PCR cycling parameters were set as follows: the RT reaction at 50°C, 2 minutes; 60°C, 30 minutes; and 95°C, 5 minutes; followed by 40 cycles of PCR reactions at 94°C, 20 seconds, and 60°C, 1 minute. The results were detected in a real-time fashion and recorded on a plot showing fluorescence vs. time. RT-PCR products were also visualized on ethidium bromide-stained 1.5% agarose (Pierce Co., Rockford, IL, USA) gel with a 100-bp ladder (Pharmacia Biotech, Piscataway, NJ, USA) as a reference. The increase of the IL12B and IFNα mRNA expression were therefore calculated assuming 100% efficient PCR where each Ct was normalized to β-actin mRNA expression as shown by the equation at 2 [Ct1(target) − Ct1(actin)][Ct2(target) − Ct2(actin)]. The Ct1 (target) and Ct2 (target) represent the Ct values for the IL12B or IFNα gene expression in treated and mock samples, respectively. Ct1 (actin) and Ct2 (actin) represent the Ct values for the β-actin gene.

Measurement of IFNa, and IL-12 p40 levels

To measure IL-12 protein production, 106 THP-1 cells with or without PMA treatment per well are seeded into 1-ml culture medium in triplicates in 24-well tissue-culture plates and incubated at 37°C in humidified 5% CO2 atmosphere in the presence or absence of different stimuli, as indicated above. After 24 and 72 hours, cell-free culture supernatants are removed and assayed for multi-species IFN-α (PBL Biomedical Laboratories, Endogene Inc., Cambridge, MA, USA), IL-12 p40 (R&D Systems, Minneapolis, MN, USA) concentrations using ELISA. The results were calculated from interpolation in a standard curve made from a series of well-known concentrations of commercial standards [30, 32].

Assessment of antibody-dependent enhancement of virus infections in differentiated THP-1 cells

To assess ADE, DEN-2 viruses were preopsonized with and without DEN-1 or DEN-2 immune sera at 4°C for 60 min as previously described [32], PMA-differentiated THP-1 cells (2 x 105cells/ml) were incubated with DEN-2 virus with and without DEN immune sera at MOI of 1 at 37°C for 60 min. The infected cells were washed to remove extracellular viruses before culture in RPMI 1640. The infected PMA-differentiated THP-1 cells were cultured for 24 hours before the culture supernatants were harvested for determination of DEN-2 virus titers by real-time RT-PCR assay for 40 cycles using TaqMan technology (Applied Biosystems, Foster City, CA). The forward primer, reverse primer and nested fluorescent probe sequence for detecting DEN-2 were 5'-GGC TTA GCG CTC ACA TCC A-3', 5'-GCT GGC CAC CCT CTC TTC TT-3', and FAM-CGC CCA CCA CTA TAG CTG CCG GA-TAMRA, respectively [30]. The intracellular viruses were harvested from the cell pellets after washing twice with PBS to remove extracellular virus. The cell pellets were frozen and thawed for three times to release intracellular DEN-2 virus, then resuspended to 20 μl and subjected to real-time RT-PCR assay.

Data and statistical analyses

Data are presented as mean ± SEM values. Mann Whiteney U test was used to analyze IL12B and IFNα RNA expression levels between undifferentiated and differentiated THP-1 cells with and without DEN-2 infection. A P value of < 0.05 was considered statistically significant. All analyses were performed using SPSS 13.0 (SPSS Inc. Chicago, IL, USA).

Results

Undifferentiated THP-1 expressing pDC markers released IFNα but not IL-12 after DEN-2 infection

In order to characterize the expression of cell markers on THP-1 cells, we assessed the CD123 levels, a pDC-specific marker, on THP-1 cells by flow cytometry. As shown in Figure 1A, CD123 was expressed on the surface of THP-1 and down-regulated on the PMA-differentiated THP-1 cells. To investigate whether THP-1 cells elicited Th1 promoting cytokines under DEN-2 infection, cellular RNA was extracted and assessed using real-time RT-PCR after 24 h infection. Higher levels of IFNα mRNA but not IL12B mRNA were induced in post-infected THP-1 cells by DEN-2 (Figure 1B).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2334-12-340/MediaObjects/12879_2012_Article_2263_Fig1_HTML.jpg
Figure 1

Flow cytometric analysis of CD123 expression in THP-1 with or without PMA differentiation (A). Expression of IFNA and IL12B mRNA expression in THP-1 cells with DEN-2 infection (B). Six RNA samples from cells were subjected to testing IFNA (■) and IL12B (□) mRNAs by SYBR Green real-time RT-PCR analysis. (p = 0.019).

Differentiated THP-1 expressing mDC markers released IL-12 but not IFNα after DEN-2 infection

THP-1 cells grew as a single-cell suspension, and only a few cells spread onto the flask substrate. Approximately 80% of the cells attached to the substrate as early as 3 h after the addition of PMA (8 nM). After a 72-h treatment with PMA, THP-1 spread onto the substrate to be irregular and flattened in shape. Addition of DMSO only at the same dilutions required for obtaining the given concentrations of PMA in culture system did not induce adherence of the cells to the substrate.

The effect of PMA treatment on the expression of surface markers of THP-1 cells was examined by flow cytometry. THP-1 treated with 8 nM PMA expressed more mDC cell markers such as CD14, CD11b, and CD11c (Figure 2A-C), but not CD123, pDC cell markers (Figure 1A). To analyze whether PMA-treated THP-1 cells elicited Th1 promoting cytokines under DEN-2 infection, cellular RNA was extracted and assessed using real-time RT-PCR after 24 h DEN-2 infection. Higher levels of IL12B mRNA but not IFNα mRNA were induced in PMA-treated THP-1 cells after 24 h DEN-2 infection (Figure 2D).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2334-12-340/MediaObjects/12879_2012_Article_2263_Fig2_HTML.jpg
Figure 2

Flow cytometric analysis of CD14, CD11b, CD11c expression in THP-1 with or without PMA differentiation (A-C). Expression of IFNA and IL12B mRNA expression in PMA-treated THP-1 cells with DEN-2 infection (D). Six RNA samples from cells were subjected to testing IFNA (■) and IL12B (□) mRNAs by SYBR Green real-time RT-PCR analysis. (p = 0.016).

Dose dependent and kinetic induction of IFNα /IL12B mRNA in THP-1 cells with or without PMA differentiation after DEN-2 infection

Undifferentiated THP-1 cells elicited higher production of IFNα mRNA (Figure 1B); PMA-treated THP-1 cells after DEN-2 infection expressed IL12B mRNA (Figure 2D). To investigate whether Th1 promoting cytokines induced in undifferentiated THP-1 cells were dose dependent, cells were infected by different DEN-2 titers (MOI = 0.1 ~ 5) and RNA were assessed by real-time RT-PCR. As shown in Figure 3A, THP-1 elicited IFNα mRNA levels when cells infected by DEN-2 even at lower MOI, and induced IFNα mRNA reached the maximum at MOI = 5. To analyze whether Th1 promoting cytokines were kinetically induced in THP-1, cells were infected by DEN-2 at MOI = 1 at different time from 30 min, 1 h, 2 h, 6 h, and 24 h. Results showed that the IFNα mRNA expressing levels were kinetically increased in undifferentiated THP-1 cells and reached the maximum at 24 h post-infection of DEN-2 (Figure 3B). Interestingly, the IL12B mRNA expressing levels were also kinetically induced and dose-dependent in PMA-differentiated THP-1 cells and reached its maximum induction at 24 h post-infection of DEN-2 (Figure 3C, D). In order to understand whether the induction of Th1 promoting cytokines were limited to transcriptional level, we assessed the cytokine levels by ELISA in the same reactions. However, we could not detect the IFNα production in the supernatants of DEN-2 infected undifferentiated THP-1 cells. However, only IL-12 p40 proteins were kinetically and dose-dependently detected in PMA differentiated THP-1 cells Results showed that IL-12 p40 production could be induced at 1 h post-infection of DEN-2 and also reached its maximum at 24 h post-infection of DEN-2 in differentiated THP-1 cells, but not in undifferentiated THP-1 cells (Figure 3E, F).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2334-12-340/MediaObjects/12879_2012_Article_2263_Fig3_HTML.jpg
Figure 3

Dose-dependent and kinetic induction of IFNA and IL12B expression in DEN-2-infected THP-1 cells with or without PMA differentiation. A series of M.O.I. of DEN-2 were assessed at post-infection 24 h, RNA samples from THP-1 (A) or PMA-differentiated THP-1 (C) cells were subjected to testing IFNA and IL12B mRNAs by SYBR Green real-time RT-PCR analysis. A different post-infection time of DEN-2 were assessed at M.O.I.=1, RNA samples from THP-1 (B) or PMA-differentiated THP-1 (D) cells were subjected to testing IFNA and IL12B mRNAs by SYBR Green real-time RT-PCR analysis. The similar dose response (E) and kinetic induction (F) of IL-12 p40 proteins in the supernatants of DEN-2 infected PMA-differentiated THP-1 cells by ELISA in the same reactions.

Down-regulation of IL12B in antibody dependent enhancement of DEN-2 infected differentiated THP-1 cells

Antibody-dependent enhancement of DEN-2 infection occurred when sub-neutralizing antibodies facilitated DEN-2 infection via Fc receptors (FcR). To investigate the role of IL-12 p40 in ADE of DEN-2 infection, we compared the viral replication and IL12B expression in the differentiated THP-1 cell using real-time RT-PCR. As shown in Figure 4A, we found that the sub-neutralizing DEN-1 antiserum could enhance DEN-2 replication in differentiated THP-1 cells from 2.64×105 copies/ml to 1.49×106 copies/ml in the presence of antiserum at 1:1250 dilution. However, anti-DEN2 antiserum at 1:1250 dilution did not enhance DEN-2 replication in differentiated THP-1 cells (2.64×105 copies/ml vs. 3.28×105 copies/ml). To measure the expression of IL-12 p40 levels in the ADE of DEN-2 infection of differentiated THP-1 cells, we found that DEN-2 infection induced a higher IL12B expression (Figure 4B). Presence of anti-DEN1 antiserum at 1:1250 dilution, but not anti-DEN2 antiserum, significantly suppressed the DEN-2 induced IL12B expression in differentiated THP-1 cells.
https://static-content.springer.com/image/art%3A10.1186%2F1471-2334-12-340/MediaObjects/12879_2012_Article_2263_Fig4_HTML.jpg
Figure 4

Enhanced DEN-2 replication but suppressed IL12B in heterotypic antibody-mediated DEN-2 infected differentiated THP-1 cells. (A) To compare viral replication, viral load of DEN-2 in antiserum-mediated DEN-2 infection was determined by TaqMan real-time RT-PCR (DEN-2 (■), anti-DEN1 antiserum + DEN-2 (░), and anti-DEN2 antiserum + DEN-2 (□), p = 0.022, 0.042, and 0.777 respectively) after infection of DEN-2 for 24 h in a summary calculated from the results of 5-paired experiments. Suppression of IL12B levels in differentiated THP-1 cells was found in the addition of anti-DEN1 antiserum diluted to 1:1250 after infection of DEN-2 for 24 h (B) (DEN-2 (■), anti-DEN1 antiserum + DEN-2 (░), and anti-DEN2 antiserum + DEN-2 (□), p = 0.024, 0.014, and 0.054 respectively) after infection of DEN-2 for 24 h in a summary calculated from the results of 5-paired experiments.

Discussion

Several prospective studies have concluded that DHF is more common in secondary DEN infections than in primary DEN infections [9, 48]. Despite extensive studies, the pathogenesis of DHF cannot be fully attributed to the ADE. Activation of dengue virus-specific T cells and dengue virus-infected monocytes may result in increased capillary permeability in patients with DHF [49, 50]. Recently, cytokines related to dominant Th2 reaction have been related to the pathogenesis of DHF [44, 48, 51, 52]. We showed that increase of Th1 cytokine, IL12B expression in differentiated THP-1 cells was found in DEN-2 infection (Figure 3C, D). We also found that heterotypic antibody mediated DEN-2 infection significantly enhanced DEN-2 replication, but suppressed the IL12B expression.

Distinct DC subsets are known to exhibit intrinsic differences in their ability to: 1) regulate the quality of the Th response (Th1, Th2, or cytotoxic T lymphocyte [CTL]); 2) produce antiviral type I IFNs; and 3) cross-present exogenous Ags to CD8+ T cells [53]. Our results indicate that treatment of human monocytic leukemia cell line, THP-1, cells with 8 nM PMA for 72 h promotes a differentiation phenotype that is characterized by morphological changes and altered IFNα gene induction. The PMA could induce THP-1 cells to differentiate toward macrophage has been well demonstrated [5456]. We however demonstrated an up-regulation in expression of mDC-related molecules associated with monocyte differentiation, notably CD11b, CD11c and CD14. Concomitantly, the expression of CD123 was selectively downregulated in the PMA differentiated THP-1 cells. Theses cell surface markers were partly similar to the criteria of differences between myloid DCs and plasmacytoid DCs. THP-1 cells induced elevated IFNα mRNA expression under DEN-2 infection, however, PMA-differentiated THP-1 cells elicited higher IL12B mRNA expression and protein levels under the same infection. The induction of early Th1 cytokines was dose-dependent and time-dependent in THP-1 with or without PMA differentiated cells.

Conclusion

Human blood DCs can be divided into several distinct phenotypic and functional subpopulations, and both monocytes-derived DCs and PMA-differentiated THP-1 cells are of the myeloid CD11b+ CD11c+ and CD14+, resembling their in vivo myeloid counterpart [29]. We showed that THP-1, likes pDCs, responded to DEN-2 by secreting IFNα; on the other hand, PMA-differentiated THP-1 cells, act as mDC, responded to DEN-2 by secreting IL-12. This model may be a good model system for studying early innate immunity of virus infections, and provide a better strategy to prevent infection and complication.

Abbreviation

ADE: 

Antibody-dependent enhancement

ALCAM: 

Activated leukocyte cell adhesion molecule

DC: 

Dendritic cell

DF: 

Dengue fever

DHF: 

Dengue hemorrhagic fever

DMSO: 

Dimethyl sulfoxide

DSS: 

Dengue shock syndrome

FBS: 

Fetal bovine serum

FcγR: 

Fc-gamma receptors

mDC: 

Myeloid dendritic cells

pDC: 

Plasmacytoid dendritic cells

PMA: 

Phorbol 12-myristate 13-acetate

RT-PCR: 

Reverse transcriptase-polymerase chain reaction

TLR: 

Toll-like receptor.

Declarations

Acknowledgements

The authors have benefited from the statistical advice by Dr. Eng-Yen Huang. This study was, in part, supported by grants NSC97-2628-B-182-001-MY3 from the National Science Council of Taiwan and NHRI-100AI-PDCO-0909111 from the National Health Research Institutes of Taiwan and RA11028 from Department of Medical Research and Development, Show Chwan Memorial Hospital, Taiwan.

Authors’ Affiliations

(1)
Department of Medical Research and Development, Show Chwan Health Care System
(2)
Department of Pediatrics, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine
(3)
Department of Biological Sciences, National Sun Yat-sen University

References

  1. Clarke T: Dengue virus: break-bone fever. Nature. 2002, 416 (6882): 672-674. 10.1038/416672a.View ArticlePubMedGoogle Scholar
  2. Thomas SJ, Strickman D, Vaughn DW: Dengue epidemiology: virus epidemiology, ecology, and emergence. Adv Virus Res. 2003, 61: 235-289.View ArticlePubMedGoogle Scholar
  3. WHO Expert Committee on Viral Haemorrhagic Fevers: Viral haemorrhagic fevers. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1985, 721: 5-126.Google Scholar
  4. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, et al: Dengue: a continuing global threat. Nat Rev Microbiol. 2010, 8 (12 Suppl): S7-S16.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV: Dengue and dengue haemorrhagic fever. Lancet. 1998, 352 (9132): 971-977. 10.1016/S0140-6736(97)12483-7.View ArticlePubMedGoogle Scholar
  6. Monath TP: Dengue: the risk to developed and developing countries. Proc Natl Acad Sci USA. 1994, 91 (7): 2395-2400. 10.1073/pnas.91.7.2395.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Butt N, Abbassi A, Munir SM, Ahmad SM, Sheikh QH: Haematological and biochemical indicators for the early diagnosis of dengue viral infection. J Coll Physicians Surg Pak. 2008, 18 (5): 282-285.PubMedGoogle Scholar
  8. Nimmannitya S: Clinical manifestations of dengue/dengue haemorrhagic fever. Monograph on dengue/dengue haemorrhagic fever. Edited by: Thongcharoen P. 1993, New Delhi: WHO-SEARO, 48-54.Google Scholar
  9. Burke DS, Nisalak A, Johnson DE, Scott RM: A prospective study of dengue infections in Bangkok. AmJTrop Med Hyg. 1988, 38 (1): 172-180.Google Scholar
  10. Halstead SB, Nimmannitya S, Cohen SN: Observations related to pathogenesis of dengue hemorrhagic fever IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med. 1970, 42 (5): 311-328.PubMedPubMed CentralGoogle Scholar
  11. Lipscomb MF, Masten BJ: Dendritic cells: immune regulators in health and disease. Physiol Rev. 2002, 82 (1): 97-130.View ArticlePubMedGoogle Scholar
  12. Mohamadzadeh M, Luftig R: Dendritic cells: In the forefront of immunopathogenesis and vaccine development - A review. J Immune Based Ther Vaccines. 2004, 2 (1): 1-10.1186/1476-8518-2-1.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Sozzani S, Vermi W, Del Prete A, Facchetti F: Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol. 2010, 31 (7): 270-277. 10.1016/j.it.2010.05.004.View ArticlePubMedGoogle Scholar
  14. Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A: The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets. 2009, 8 (1): 40-52. 10.2174/187152809787582507.View ArticlePubMedGoogle Scholar
  15. Rajkovic I, Dragicevic A, Vasilijic S, Bozic B, Dzopalic T, Tomic S, Majstorovic I, Vucevic D, Djokic J, Balint B, et al: Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans'-like cells. Immunology. 2011, 132 (2): 217-225. 10.1111/j.1365-2567.2010.03356.x.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Yu HR, Chen RF, Hong KC, Bong CN, Lee WI, Kuo HC, Yang KD: IL-12-independent Th1 polarization in human mononuclear cells infected with varicella-zoster virus. Eur J Immunol. 2005, 35 (12): 3664-3672. 10.1002/eji.200526258.View ArticlePubMedGoogle Scholar
  17. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE, Freedman VH, Kaplan G: Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci USA. 2001, 98 (10): 5752-5757. 10.1073/pnas.091096998.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Cousens LP, Peterson R, Hsu S, Dorner A, Altman JD, Ahmed R, Biron CA: Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med. 1999, 189 (8): 1315-1328. 10.1084/jem.189.8.1315.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Kumar H, Kawai T, Akira S: Pathogen recognition by the innate immune system. Int Rev Immunol. 2011, 30 (1): 16-34. 10.3109/08830185.2010.529976.View ArticlePubMedGoogle Scholar
  20. Katashiba Y, Miyamoto R, Hyo A, Shimamoto K, Murakami N, Ogata M, Amakawa R, Inaba M, Nomura S, Fukuhara S, et al: Interferon-alpha and interleukin-12 are induced, respectively, by double-stranded DNA and single-stranded RNA in human myeloid dendritic cells. Immunology. 2011, 132 (2): 165-173. 10.1111/j.1365-2567.2010.03350.x.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, Uehira K, Ozaki Y, Tomizawa H, Akira S, Fukuhara S: Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med. 2002, 195 (11): 1507-1512. 10.1084/jem.20020207.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Palmer DR, Sun P, Celluzzi C, Bisbing J, Pang S, Sun W, Marovich MA, Burgess T: Differential effects of dengue virus on infected and bystander dendritic cells. J Virol. 2005, 79 (4): 2432-2439. 10.1128/JVI.79.4.2432-2439.2005.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Pollara G, Jones M, Handley ME, Rajpopat M, Kwan A, Coffin RS, Foster G, Chain B, Katz DR: Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion. J Immunol. 2004, 173 (6): 4108-4119.View ArticlePubMedGoogle Scholar
  24. Ito T, Wang YH, Liu YJ: Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol. 2005, 26 (3): 221-229. 10.1007/s00281-004-0180-4.View ArticlePubMedGoogle Scholar
  25. Roses RE, Xu S, Xu M, Koldovsky U, Koski G, Czerniecki BJ: Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. J Immunol. 2008, 181 (7): 5120-5127.View ArticlePubMedGoogle Scholar
  26. Rutella S, Danese S, Leone G: Tolerogenic dendritic cells: cytokine modulation comes of age. Blood. 2006, 108 (5): 1435-1440. 10.1182/blood-2006-03-006403.View ArticlePubMedGoogle Scholar
  27. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995, 182 (2): 389-400. 10.1084/jem.182.2.389.View ArticlePubMedGoogle Scholar
  28. Jalili A: Dendritic cells and their role in cancer immunotherapy. Iran J Immunol. 2007, 4 (3): 127-144.PubMedGoogle Scholar
  29. Larsson K, Lindstedt M, Borrebaeck CA: Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells. Immunology. 2006, 117 (2): 156-166. 10.1111/j.1365-2567.2005.02274.x.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Chen RF, Yeh WT, Yang MY, Yang KD: A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. FEMS Immunol Med Microbiol. 2001, 30 (1): 1-7. 10.1111/j.1574-695X.2001.tb01542.x.View ArticlePubMedGoogle Scholar
  31. Guzman MG: Global voices of science. Deciphering dengue: the Cuban experience. Science. 2005, 309 (5740): 1495-1497. 10.1126/science.1115177.View ArticlePubMedGoogle Scholar
  32. Yang KD, Yeh WT, Yang MY, Chen RF, Shaio MF: Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production. J Med Virol. 2001, 63 (2): 150-157. 10.1002/1096-9071(20000201)63:2<150::AID-JMV1010>3.0.CO;2-A.View ArticlePubMedGoogle Scholar
  33. Chen RF, Liu JW, Yeh WT, Wang L, Chang JC, Yu HR, Cheng JT, Yang KD: Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol. 2005, 44 (1): 43-50. 10.1016/j.femsim.2004.11.012.View ArticlePubMedGoogle Scholar
  34. Nagahara Y, Nagamori T, Tamegai H, Hitokuwada M, Yoshimi Y, Ikekita M, Shinomiya T: Inulin stimulates phagocytosis of PMA-treated THP-1 macrophages by involvement of PI3-kinases and MAP kinases. Biofactors. 2011, 37 (6): 447-454. 10.1002/biof.186.View ArticlePubMedGoogle Scholar
  35. Barilli A, Rotoli BM, Visigalli R, Bussolati O, Gazzola GC, Dall'Asta V: Arginine transport in human monocytic leukemia THP-1 cells during macrophage differentiation. J Leukoc Biol. 2011, 90 (2): 293-303. 10.1189/jlb.0910510.View ArticlePubMedGoogle Scholar
  36. Maess MB, Sendelbach S, Lorkowski S: Selection of reliable reference genes during THP-1 monocyte differentiation into macrophages. BMC Mol Biol. 2010, 11: 90-10.1186/1471-2199-11-90.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Traore K, Trush MA, George M, Spannhake EW, Anderson W, Asseffa A: Signal transduction of phorbol 12-myristate 13-acetate (PMA)-induced growth inhibition of human monocytic leukemia THP-1 cells is reactive oxygen dependent. Leuk Res. 2005, 29 (8): 863-879. 10.1016/j.leukres.2004.12.011.View ArticlePubMedGoogle Scholar
  38. Bremner TA, D'Costa N, Dickson LA, Asseffa A: A decrease in glucose 6-phosphate dehydrogenase activity and mRNA is an early event in phorbol ester-induced differentiation of thp-1 promonocytic leukemia cells. Life Sci. 1996, 58 (12): 1015-1022. 10.1016/0024-3205(96)00050-1.View ArticlePubMedGoogle Scholar
  39. Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B, Marovich MA: Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol. 2011, 85 (4): 1671-1683. 10.1128/JVI.00220-10.View ArticlePubMedGoogle Scholar
  40. Chareonsirisuthigul T, Kalayanarooj S, Ubol S: Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol. 2007, 88 (Pt 2): 365-375.View ArticlePubMedGoogle Scholar
  41. Wang L, Chen RF, Liu JW, Lee IK, Lee CP, Kuo HC, Huang SK, Yang KD: DC-SIGN (CD209) Promoter −336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation. PLoS Negl Trop Dis. 2011, 5 (1): e934-10.1371/journal.pntd.0000934.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Chen RF, Wang L, Cheng JT, Chuang H, Chang JC, Liu JW, Lin IC, Yang KD: Combination of CTLA-4 and TGFbeta1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak. Clin Immunol. 2009, 131 (3): 404-409. 10.1016/j.clim.2009.01.015.View ArticlePubMedGoogle Scholar
  43. Wang L, Chen RF, Liu JW, Yu HR, Kuo HC, Yang KD: Implications of dynamic changes among tumor necrosis factor-alpha (TNF-alpha), membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection. AmJTrop Med Hyg. 2007, 77 (2): 297-302.Google Scholar
  44. Chen RF, Yang KD, Wang L, Liu JW, Chiu CC, Cheng JT: Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans R Soc Trop Med Hyg. 2007, 101 (11): 1106-1113. 10.1016/j.trstmh.2007.06.019.View ArticlePubMedGoogle Scholar
  45. Yeh WT, Chen RF, Wang L, Liu JW, Shaio MF, Yang KD: Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunol Med Microbiol. 2006, 48 (1): 84-90. 10.1111/j.1574-695X.2006.00127.x.View ArticlePubMedGoogle Scholar
  46. Yu HR, Chang JC, Chen RF, Chuang H, Hong KC, Wang L, Yang KD: Different antigens trigger different Th1/Th2 reactions in neonatal mononuclear cells (MNCs) relating to T-bet/GATA-3 expression. J Leukoc Biol. 2003, 74 (5): 952-958. 10.1189/jlb.0902474.View ArticlePubMedGoogle Scholar
  47. Nudelman G, Ge Y, Hu J, Kumar M, Seto J, Duke JL, Kleinstein SH, Hayot F, Sealfon SC, Wetmur JG: Coregulation mapping based on individual phenotypic variation in response to virus infection. Immunome Res. 2010, 6: 2-10.1186/1745-7580-6-2.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Pang T, Cardosa MJ, Guzman MG: Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol. 2007, 85 (1): 43-45. 10.1038/sj.icb.7100008.View ArticlePubMedGoogle Scholar
  49. Friberg H, Bashyam H, Toyosaki-Maeda T, Potts JA, Greenough T, Kalayanarooj S, Gibbons RV, Nisalak A, Srikiatkhachorn A, Green S, et al: Cross-Reactivity and Expansion of Dengue-Specific T cells During Acute Primary and Secondary Infections in Humans. Sci Rep. 2011, 1: 51-View ArticlePubMedPubMed CentralGoogle Scholar
  50. Wahala WM, Silva AM: The human antibody response to dengue virus infection. Viruses. 2011, 3 (12): 2374-2395. 10.3390/v3122374.View ArticlePubMedPubMed CentralGoogle Scholar
  51. Pawitan JA: Dengue virus infection: predictors for severe dengue. Acta Med Indones. 2011, 43 (2): 129-135.PubMedGoogle Scholar
  52. Restrepo BN, Ramirez RE, Arboleda M, Alvarez G, Ospina M, Diaz FJ: Serum levels of cytokines in two ethnic groups with dengue virus infection. AmJTrop Med Hyg. 2008, 79 (5): 673-677.Google Scholar
  53. Pulendran B: Variegation of the immune response with dendritic cells and pathogen recognition receptors. J Immunol. 2005, 174 (5): 2457-2465.View ArticlePubMedGoogle Scholar
  54. Rovera G, Ferrero D, Pagliardi GL, Vartikar J, Pessano S, Bottero L, Abraham S, Lebman D: Induction of differentiation of human myeloid leukemias by phorbol diesters: phenotypic changes and mode of action. Ann N Y Acad Sci. 1982, 397: 211-220. 10.1111/j.1749-6632.1982.tb43428.x.View ArticlePubMedGoogle Scholar
  55. Kamiya T, Makino J, Hara H, Inagaki N, Adachi T: Extracellular-superoxide dismutase expression during monocytic differentiation of U937 cells. J Cell Biochem. 2011, 112 (1): 244-255. 10.1002/jcb.22917.View ArticlePubMedGoogle Scholar
  56. Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH: The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One. 2010, 5 (1): e8668-10.1371/journal.pone.0008668.View ArticlePubMedPubMed CentralGoogle Scholar
  57. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/12/340/prepub

Copyright

© Chen et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement